meta_pixel
Tapesearch Logo
Log in
Everyday Wellness with Cynthia Thurlow ™

Ep. 262 Ozempic: Exploring the Benefits and Uses - A Comprehensive Review with Dr. Tracy Gapin

Everyday Wellness with Cynthia Thurlow ™

Cynthia Thurlow

Alternative Health, Nutrition, Science, Life Sciences, Health & Fitness

4.81K Ratings

🗓️ 25 March 2023

⏱️ 53 minutes

🧾️ Download transcript

Summary

I am honored to reconnect with Dr. Tracy Gapin today. He is a board-certified urologist and men’s health expert. The current state of metabolic health in the United States and most westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. So I wanted to talk to a clinician actively utilizing this medication. Dr. Gapin and I discuss what this drug class represents. (These are synthetic peptides.) We speak about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. We get into current research, side effects, who should not take these medications, and the mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety. We discuss changes in the brain regarding leptin and how these drugs work. We also talk about weight loss resistance, and I answer questions from listeners. From my perspective, it all comes back to basics. I believe that if we are to prescribe these medications, we must help our patients understand how lifestyle impacts weight-loss resistance and metabolic health. I loved that Dr. Tracy spent some time talking about the specific ways he works with his patients, even before prescribing medications. He also explains how important he has felt this drug has been for his patients. I approached today’s conversation with an open mind, and I hope you will do the same. IN THIS EPISODE YOU WILL LEARN: How the GLP1 agonists help Dr. Tracy motivate his patients to lose weight. What are GLP1 agonists, and how do they work? The physical benefits of GLP1 agonists. Who is Semaglutide not appropriate for? Some of the common side-effects of GLP1 agonists. How those who fail to implement lifestyle changes when they stop using Semaglutide may regain all the weight they lost. Why it is essential to stay hydrated when using Semaglutide. Why you need to eat enough food- protein in particular when taking Semaglutide. How to follow the metrics that matter. Some factors that could hinder successful weight loss. What Dr. Tracy does to ensure his patients do not regain the weight they lost after they stop using Semaglutide. Listener questions: Why is a diabetic drug being used for non-diabetics? Does this drug target muscle versus fat in terms of weight loss? For how long do most patients take it? Are there unique characteristics in perimenopausal and menopausal women that must be accounted for differently? Bio: Dr. Tracy Gapin is a board-certified urologist, a world-renowned men’s health & performance expert, and the founder of the Gapin Institute, the global leader in High-Performance Health. He has over 20 years of experience focused on men’s health optimization, human performance, and longevity, providing executives & entrepreneurs a personalized path to fulfill their highest potential. He’s been featured in Entrepreneur, Dave Asprey’s Biohacking Conference, and as a TEDx speaker. Connect with Cynthia Thurlow Follow on Twitter, Instagram & LinkedIn Check out Cynthia’s website Connect with Tracy Gapin On his website Gapin Institute Text “Health” to 26786 to receive 10 Secrets to High-Performance Health and a free copy of Dr. Gapin’s book.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Everyday Wellness Podcast. I'm your host, Nurse Practitioner Cynthia Thurlow.

0:07.0

This podcast is designed to educate, empower, and inspire you to achieve your health and wellness goals.

0:14.0

My goal and intent is to provide you with the best content and conversations from leaders in the

0:19.2

health and wellness industry each week and impact over a million lives.

0:23.4

Today I had the honor of reconnecting with Dr. Tracy Gappin. He is a board certified urologist and

0:35.4

men's health expert and with the current state of metabolic health in the

0:40.7

United States and actually in most Westernized countries. There's been great interest in a GLP1 agonist, aka semi-glutide Ozempeck. And I wanted to bring a clinician on that is actively utilizing this medication.

0:57.1

We spoke about what this drug class represents.

1:00.3

These are synthetic peptides. We spoke at great length about semi-glutide in particular as well as

1:07.3

Ozempeck and Weagovi as well as oral rivalous. We discussed current research, side effects who should not take these medications and spent quite a bit of time talking about mechanisms of action specific to the pancreas and beta cells, reductions in gastric emptying and satiety being upregulated, as well as specific changes in the brain with regard to lepton and how these drugs work and manifest. We spoke about weight loss resistance. I answered many listeners questions. Thank you for submitting those. And you know, from my perspective, it really comes back to basics. If we are going to be prescribing these medications and let me be clear I'm not currently doing so, but if we are going to be prescribing these medications, we owe our patients the opportunity to really understand how lifestyle impacts

1:58.4

weight loss resistance as well as metabolic health and I love that Dr. Tracy spent quite a bit of time talking about

2:04.8

specific ways that he works with his patients even prior to prescribing medications

2:10.4

but how important he has felt that this drug has been to his given patient population and I think I went into this conversation with a very open mind and I hope you will

2:25.0

to have you back.

2:27.0

Thank you for carving time out of your busy schedule to talk about a topic that is getting a lot of attention,

2:33.2

Ozemphic, semi-glutide, Weagovi, all these drugs.

2:38.8

Tell me from your perspective, I mean, obviously you've been a urologist for a long time.

2:44.4

When did they kind of fall onto your radar in terms of your given patient population and you work in full disclosure

2:49.8

you work with men but still when did you start utilizing these drugs and what has been kind of the

2:57.0

progression of using them or using them with greater frequency now? I'm sure people are probably coming directly to you and

3:03.5

asking for them. Yeah, yeah, absolutely. And first of all, thanks so much for having me

3:07.4

on your show again today. I love you. I love all your content. You're amazing human being, so I'm glad to be with you tonight, first of all.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Cynthia Thurlow, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Cynthia Thurlow and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.